← Back to Clinical Trials
Recruiting NCT07758543

NCT07758543 Combined Effects of Proprioceptive Neuromuscular Facilitation (PNF) and Neural Mobilization on Improving Facial Symmetry in Patients With Bells Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07758543
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Bell's Palsy
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2025-09-14
Primary Completion 2026-12-10

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
GROUP A COMBINED THERAPY GROUPGROUP B PNF GROUP

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2025-09-14 with a primary completion date of 2026-12-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Bell's palsy is an acute,unilateral facial paresis that significantly affects patient's facial symmetry,motor function and quality of life.The primary goal of this randomized controlled trial is to determine if integrating the targeted neural mobilization with proprioceptive neuromuscular facilitation improves facial symmetry and motor function more effectively than using pnf alone.participants allocated to either experimental group receiving neural mobilization and pnf or control group receiving pnf alone.after approval from ERC FUSH, participants are assessed using housebrackman scale and sunnybrook facial grading system(scales to asses the degree of severity of facial paralysis) at first and fourth week of intervention application.data will be analysed using spss v.22.

Eligibility Criteria

Inclusion Criteria: * Age 15-60 years. * Both male and female. * Patient diagnosed with bells palsy by neurologist or relevant specialist. * Patients with moderate to severe Bell's palsy evaluated by Modified House-Brackman SCALE * Patient without exposure to any other rehabilitation program * Patients within the acute or subacute phases (within 6 months of onset) Exclusion Criteria: * Patients with a history of recurrent Bell's palsy or other neurological disorders (e.g., stroke, multiple sclerosis) * Patients with pacemakers, metal implants or other contraindications for electrical muscle stimulation. * Presence of facial trauma or surgical interventions that might interfere with rehabilitation outcomes. * Co-existing medical conditions (e.g., diabetes mellitus, infections, or malignancies) that might impair nerve recovery or affect study outcomes

Contact & Investigator

Central Contact

Mahnoor Azhar, DPT

✉ mahnoorazhar707@gmail.com

📞 +92 3175868174

Frequently Asked Questions

Who can join the NCT07758543 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 60 Years, studying Bell's Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07758543 currently recruiting?

Yes, NCT07758543 is actively recruiting participants. Contact the research team at mahnoorazhar707@gmail.com for enrollment information.

Where is the NCT07758543 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07758543 clinical trial?

NCT07758543 is sponsored by Foundation University Islamabad. The trial plans to enroll 38 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology